当前位置: »论坛 › 科研专区 › 文献互助› Enhanced preclinical antitumor activity of M7824, a ...

[AAAS] Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

DannyDannydd 发表于 1 小时前 | 显示全部楼层 |阅读模式

此帖将于 2026-08-22 14:03 自动关闭

悬赏10积分

期刊：Science Translational Medicine

文献作者：Yan Lan; Dong Zhang; Chunxiao Xu; Kenneth W. Hance; Bo Marelli; Jin Qi; Huakui Yu; Guozhong Qin; Aroop Sircar; Vivian M. Hernández; Molly H. Jenkins; Rachel E. Fontana; Amit Deshpande; George Locke; Helen Sabzevari; Laszlo Radvanyi; Kin-Ming Lo

出版日期：2018-1-17

DOI号：10.1126/scitranslmed.aan5488

下载链接：https://www.science.org/doi/pdf/10.1126/scitranslmed.aan5488

文献链接：https://doi.org/10.1126/scitranslmed.aan5488

当前文献来源于 American Association for the Advancement of Science (AAAS)。

备注信息：

使用道具捐赠获取积分应助有误反馈

全部回复0 显示全部楼层

发表回复

DannyDannydd Lv.2

注册会员

发布
回复
积分
30

同分类求助

10 Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

[AAAS] Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AAAS] Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AAAS] Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β